Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Bortezomib × Clear all

NCT00052507 2015-07-23

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms